A5078430284- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Stroke Rehabilitation and Recovery
- COVID-19 and healthcare impacts
- Blood disorders and treatments
- Tracheal and airway disorders
- Esophageal and GI Pathology
- Heparin-Induced Thrombocytopenia and Thrombosis
- Long-Term Effects of COVID-19
- Cerebral Venous Sinus Thrombosis
- Child and Adolescent Health
- Pulmonary Hypertension Research and Treatments
- Atrial Fibrillation Management and Outcomes
- Child and Adolescent Psychosocial and Emotional Development
- Child Nutrition and Feeding Issues
- Dysphagia Assessment and Management
Cooper University Hospital
2021-2022
Background We report the interim results of a process improvement initiative at comprehensive stroke center in which all tPA (tissue‐type plasminogen activator)–eligible patients were given tenecteplase for acute ischemic stroke. Methods retrospectively analyzed prospectively maintained single‐center registry consecutive with treated our emergency department or transferred further care. Patients alteplase (tPA) before (October 2019–April 2020) compared those (May 2020–July 2021). The primary...
ObjectiveTo characterize differences in disposition arrangement among rehab-eligible stroke patients at a Comprehensive Stroke Center before and during the COVID-19 pandemic.Materials MethodsWe retrospectively analyzed prospective registry for demographics, hospital course, discharge dispositions of acute survivors admitted 6 months prior to (10/2019-03/2020) (04/2020-09/2020) pandemic. The primary outcome was an inpatient rehabilitation facility (IRF) as opposed other facilities using...
We implemented a multi-disciplinary process improvement intervention at our Comprehensive Stroke Center with speech/language pathologists to expedite oral medication delivery in stroke patients. Following failed nursing dysphagia screen, trained neurology physicians screened further approve use of medications. analyzed the safety and efficacy this intervention.We retrospectively collected data for hospital course, timing first use, complications (e.g., aspiration pneumonia) consecutive...
NA
Introduction: Ipsilateral nonstenotic (<50%) internal carotid artery (ICA) plaque, cardiac atriopathy, and patent foramen ovale (PFO) may account for a substantial proportion of embolic stroke undetermined source (ESUS). Methods: Consecutive patients at our center (2019-2021) with unilateral, anterior ESUS were categorized into the following mutually exclusive etiologies: (1) ipsilateral ICA plaque (≥3mm), (2) atriopathy (sex-adjusted mod-to-severe atrial enlargement) & (3) PFO....